BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vogel J, Berman AT, Lin L, Pechet TT, Levin WP, Gabriel P, Khella SL, Singhal S, Kucharczuk JK, Simone CB 2nd. Prospective study of proton beam radiation therapy for adjuvant and definitive treatment of thymoma and thymic carcinoma: Early response and toxicity assessment. Radiother Oncol. 2016;118:504-509. [PMID: 26895711 DOI: 10.1016/j.radonc.2016.02.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Forsthoefel MK, Ballew E, Unger KR, Ahn PH, Rudra S, Pang D, Collins SP, Dritschilo A, Harter W, Paudel N, Collins BT, Lischalk JW. Early Experience of the First Single-Room Gantry Mounted Active Scanning Proton Therapy System at an Integrated Cancer Center. Front Oncol 2020;10:861. [PMID: 32547953 DOI: 10.3389/fonc.2020.00861] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Gomez DR, Rimner A, Simone CB 2nd, Cho BCJ, de Perrot M, Adjei AA, Bueno R, Gill RR, Harpole DH Jr, Hesdorffer M, Hirsch FR, Jackson AA, Pass HI, Rice DC, Rusch VW, Tsao AS, Yorke E, Rosenzweig K. The Use of Radiation Therapy for the Treatment of Malignant Pleural Mesothelioma: Expert Opinion from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation. J Thorac Oncol. 2019;14:1172-1183. [PMID: 31125736 DOI: 10.1016/j.jtho.2019.03.030] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 10.5] [Reference Citation Analysis]
3 Süveg K, Putora PM, Joerger M, Iseli T, Fischer GF, Ammann K, Glatzer M. Radiotherapy for thymic epithelial tumours: a review. Transl Lung Cancer Res 2021;10:2088-100. [PMID: 34012817 DOI: 10.21037/tlcr-20-458] [Reference Citation Analysis]
4 Rico M, Flamarique S, Casares C, García T, López M, Martínez M, Serrano J, Blanco M, Hernanz R, de Ingunza-Barón L, Marcos FJ, Couñago F. GOECP/SEOR radiotherapy guidelines for thymic epithelial tumours. World J Clin Oncol 2021; 12(4): 195-216 [PMID: 33959475 DOI: 10.5306/wjco.v12.i4.195] [Reference Citation Analysis]
5 Lideståhl A, Mondlane G, Gubanski M, Lind PA, Siegbahn A. An in silico planning study comparing doses and estimated risk of toxicity in 3D-CRT, IMRT and proton beam therapy of patients with thymic tumours. Physica Medica 2019;60:120-6. [DOI: 10.1016/j.ejmp.2019.03.028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
6 Willmann J, Rimner A. The expanding role of radiation therapy for thymic malignancies. J Thorac Dis. 2018;10:S2555-S2564. [PMID: 30206499 DOI: 10.21037/jtd.2018.01.154] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
7 Patel NV, Yu NY, Koroulakis A, Diwanji T, Sawant A, Sio TT, Mohindra P. Proton therapy for thoracic malignancies: a review of oncologic outcomes. Expert Rev Anticancer Ther 2021;21:177-91. [PMID: 33118427 DOI: 10.1080/14737140.2021.1844567] [Reference Citation Analysis]
8 Mercado CE, Hartsell WF, Simone CB, Tsai HK, Vargas CE, Zhu HJ, Henderson RH, Zeng J, Larson GL, Hoppe BS. Proton therapy for thymic malignancies: multi-institutional patterns-of-care and early clinical outcomes from the proton collaborative group and the university of Florida prospective registries. Acta Oncologica 2019;58:1036-40. [DOI: 10.1080/0284186x.2019.1575981] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
9 Yang AJ, Choi SH, Byun HK, Kim HJ, Lee CG, Cho J. The role of salvage radiotherapy in recurrent thymoma. Radiat Oncol J 2019;37:193-200. [PMID: 31591867 DOI: 10.3857/roj.2019.00066] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Haefner MF, Verma V, Bougatf N, Mielke T, Tonndorf-Martini E, König L, Rwigema JM, Simone CB 2nd, Uhlmann L, Eichhorn F, Winter H, Grosch H, Haberer T, Herfarth K, Debus J, Rieken S. Dosimetric comparison of advanced radiotherapy approaches using photon techniques and particle therapy in the postoperative management of thymoma. Acta Oncol 2018;57:1713-20. [PMID: 30264630 DOI: 10.1080/0284186X.2018.1502467] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
11 Vogel J, Lin L, Simone CB 2nd, Berman AT. Risk of major cardiac events following adjuvant proton versus photon radiation therapy for patients with thymic malignancies. Acta Oncol 2017;56:1060-4. [PMID: 28338373 DOI: 10.1080/0284186X.2017.1302097] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
12 Rice SR, Li YR, Busch TM, Kim MM, McNulty S, Dimofte A, Zhu TC, Cengel KA, Simone CB 2nd. A Novel Prospective Study Assessing the Combination of Photodynamic Therapy and Proton Radiation Therapy: Safety and Outcomes When Treating Malignant Pleural Mesothelioma. Photochem Photobiol. 2019;95:411-418. [PMID: 30485442 DOI: 10.1111/php.13065] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
13 Verma V, Lin L, Simone CB 2nd. Proton Beam Therapy for Bronchogenic Adenoid Cystic Carcinoma: Dosimetry, Toxicities, and Outcomes. Int J Part Ther 2018;4:1-9. [PMID: 31773012 DOI: 10.14338/IJPT-17-00014.1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Vogel J, Lin L, Litzky LA, Berman AT, Simone CB 2nd. Predicted Rate of Secondary Malignancies Following Adjuvant Proton Versus Photon Radiation Therapy for Thymoma. Int J Radiat Oncol Biol Phys. 2017;99:427-433. [PMID: 28871993 DOI: 10.1016/j.ijrobp.2017.04.022] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
15 Franceschini D, Cozzi L, Loi M, Franzese C, Reggiori G, Mancosu P, Clivio A, Fogliata A, Scorsetti M. Volumetric modulated arc therapy vs intensity-modulated proton therapy in the postoperative irradiation of thymoma. J Cancer Res Clin Oncol. 2020;146:2267-2276. [PMID: 32514629 DOI: 10.1007/s00432-020-03281-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Guttmann DM, Frick MA, Carmona R, Deville C, Levin WP, Berman AT, Chinniah C, Hahn SM, Plastaras JP, Simone CB. A prospective study of proton reirradiation for recurrent and secondary soft tissue sarcoma. Radiotherapy and Oncology 2017;124:271-6. [DOI: 10.1016/j.radonc.2017.06.024] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
17 Thariat J, Tessonnier T, Bonvalot S, Lerouge D, Mammar H, Bolle S, Claren A, Duffaud F, Alapetite C, Vogin G. La protonthérapie comme modalité d’irradiation dans les sarcomes des os ou cartilage et des tissus mous, état des lieux en 2018. Bulletin du Cancer 2018;105:830-8. [DOI: 10.1016/j.bulcan.2018.05.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Hao XJ, Peng B, Zhou Z, Yang XQ. Prospective Study of Stereotactic Body Radiation Therapy for Thymoma and Thymic Carcinoma: Therapeutic Effect and Toxicity Assessment. Sci Rep 2017;7:13549. [PMID: 29051511 DOI: 10.1038/s41598-017-12909-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
19 Simone CB, Houshmand S, Kalbasi A, Salavati A, Alavi A. PET-Based Thoracic Radiation Oncology. PET Clinics 2016;11:319-32. [DOI: 10.1016/j.cpet.2016.03.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
20 Rwigema JM, Verma V, Lin L, Berman AT, Levin WP, Evans TL, Aggarwal C, Rengan R, Langer C, Cohen RB, Simone CB 2nd. Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer. Cancer. 2017;123:4244-4251. [PMID: 28678434 DOI: 10.1002/cncr.30870] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
21 Verma V, Rwigema JM, Malyapa RS, Regine WF, Simone CB. Systematic assessment of clinical outcomes and toxicities of proton radiotherapy for reirradiation. Radiotherapy and Oncology 2017;125:21-30. [DOI: 10.1016/j.radonc.2017.08.005] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 8.5] [Reference Citation Analysis]
22 McGunigal M, Margolis M, Forsthoefel M, Singh T, Amarell K, Deblois D, Campbell L, Kim C, Liu S, Bergquist PJ, Debrito P, Collins BT, Giaccone G, Lischalk JW. Thymic malignancies treated with active scanning proton beam radiation and Monte Carlo planning: early clinical experience. Acta Oncol 2021;60:649-52. [PMID: 33629926 DOI: 10.1080/0284186X.2021.1887516] [Reference Citation Analysis]
23 Rimner A, Yao X, Huang J, Antonicelli A, Ahmad U, Korst RJ, Detterbeck F, Gomez DR. Postoperative Radiation Therapy Is Associated with Longer Overall Survival in Completely Resected Stage II and III Thymoma-An Analysis of the International Thymic Malignancies Interest Group Retrospective Database. J Thorac Oncol. 2016;11:1785-1792. [PMID: 27346413 DOI: 10.1016/j.jtho.2016.06.011] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 7.4] [Reference Citation Analysis]
24 Badiyan SN, Molitoris JK, Zhu M, Glass E, Diwanji T, Simone CB 2nd. Proton beam therapy for malignant pleural mesothelioma. Transl Lung Cancer Res. 2018;7:189-198. [PMID: 29876318 DOI: 10.21037/tlcr.2018.04.07] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]